Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-047034
Filing Date
2024-04-23
Accepted
2024-04-23 17:03:54
Documents
17
Period of Report
2024-04-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A acet-20240423.htm   iXBRL DEF 14A 1316756
2 GRAPHIC img105727553_0.jpg GRAPHIC 3411
3 GRAPHIC img105727553_1.jpg GRAPHIC 3411
4 GRAPHIC img105727553_2.jpg GRAPHIC 21591
5 GRAPHIC img105727553_3.jpg GRAPHIC 22579
6 GRAPHIC img105727553_4.jpg GRAPHIC 527418
7 GRAPHIC img105727553_5.jpg GRAPHIC 183394
  Complete submission text file 0000950170-24-047034.txt   3881905

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acet-20240423.xsd EX-101.SCH 40635
20 EXTRACTED XBRL INSTANCE DOCUMENT acet-20240423_htm.xml XML 241739
Mailing Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38359 | Film No.: 24865615
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)